-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Idexx Laboratories Inc /De quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Idexx Laboratories Inc /De Operating Income (Loss) for the quarter ending June 30, 2024 was $264M, a 10.9% decline year-over-year.
- Idexx Laboratories Inc /De Operating Income (Loss) for the twelve months ending June 30, 2024 was $1.08B, a 3.38% increase year-over-year.
- Idexx Laboratories Inc /De annual Operating Income (Loss) for 2023 was $1.1B, a 22.1% increase from 2022.
- Idexx Laboratories Inc /De annual Operating Income (Loss) for 2022 was $899M, a 3.57% decline from 2021.
- Idexx Laboratories Inc /De annual Operating Income (Loss) for 2021 was $932M, a 34.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)